Supporting high quality evaluation of
CCP throughout Europe

Learn more >


SUPPORT-E - SUPPORTing high quality
evaluation of Covid-19 convalescent plasma
throughout Europe -
is a research project
supported by the European Commission which
brings together major European Blood
Establishments. Its aim is to support high quality

clinical and scientific evaluation of Covid-19
Convalescent Plasma (CCP), using among other things
the dedicated database created by the European Commission.
The main goal of the project is to help EU countries
in both assessing the efficacy of a new therapeutic
solution to deal with the current Coronavirus crisis and
developing new strategies to face potential future pandemics.

Learn more about Support-e >
Learn more about the CCP Database >



Support High Quality
CCP donation


Support High Quality CCP Evaluation in clinical trials and monitored access use programmes


Deliver Recommendations for the collection and use of CCP in EU member states to treat Covid-19


Deliver Recommendations for future outbreaks


Ensure EU wide adoptions of recommendations and project legacy


SUPPORT-E Consortium: “Covid-19 convalescent plasma should be further investigated”

On December 7th, the WHO updated its living guideline on COVID-19 therapeutics, including convalescent plasma (CCP). This led to their recommendation against the use of CCP for COVID-19 patients. As the SUPPORT-E Consortium we wish to respond to these recommendations.
Learn more >

A brief talk with Support-e Team (WP2)

Dr. Hubert Schrezenmeier, Deutsches Rotes Kreuz – Blutspendedienst Baden-Wüttemberg | Hessen GGMBH, is the team leader of Work Package 2 of Support-e project. In this brief interview, he will explain the objectives and the state-of-the-art of the activites of WP2.
Learn more >

“A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in CCP”, a WP4 paper on Transfusion

Learn more >